Cargando…

PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome

OBJECTIVES: To compare the metabolic and hormonal features of metabolically unhealthy obese PCOS women (MU-PCOS) vs. metabolically healthy obese PCOS women (MH-PCOS) and determine whether alterations in non-esterified free fatty acids (NEFA) response to hyperinsulinemia contribute to variations in i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azziz, Ricardo, Chen, Ida Y, Ezeh, Uche
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627729/ http://dx.doi.org/10.1210/jendso/bvac150.1435

Ejemplares similares

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
por: Chen, Yen-Hao, et al.
Publicado: (2023)

PMON227 Rare ovarian luteinized fibrothecoma as cause of severe hyperandrogenism in a pre-menopausal woman.
por: Mikkilineni, Pushyami, et al.
Publicado: (2022)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

PMON243 Metabolic Disorders Genetically Modify Polycystic Ovary Syndrome through its Candidate Hormones
por: Actkins, Ky’Era, et al.
Publicado: (2022)

Skeletal Muscle Health in Polycystic Ovary Syndrome: Protective Effect of Hyperandrogenism or Detrimental Effect of Insulin Resistance? A Systematic Review and Meta-Analysis
por: Kazemi, Maryam, et al.
Publicado: (2021)

Post Menopausal Hyperandrogenism: A Case of a Steroid Cell Tumor of the Ovary
por: Hassan Nelson, Lauren Juliette, et al.
Publicado: (2021)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

OR31-01 A Randomized Controlled Trial of a Lifestyle Intervention with Longitudinal Follow up on Ovarian Dysmorphology, Hyperandrogenism, and Menstrual Irregularity in Women with Polycystic Ovary Syndrome
por: Kazemi, Maryam, et al.
Publicado: (2020)

PMON219 Disparities in Musculoskeletal Health Profiles Across Race and Ethnicity in United States-Based Women with Polycystic Ovary Syndrome per the 2018 International Guideline
por: Kazemi, Maryam, et al.
Publicado: (2022)

PMON220 Women With Polycystic Ovary Syndrome Have Worse Lifestyle Behaviors Compared to Controls: A Systematic Review and Meta-Analysis of 36,360 Women
por: Ganga, Kiran, et al.
Publicado: (2022)

THU643 Hyperandrogenism Caused By A Steroid Cell Tumor Of The Ovary In A Postmenopausal Woman
por: Mon Myint, Myat Su, et al.
Publicado: (2023)

RF10 | PMON249 MicroRNA-21 Ablation Exacerbates Androgen-Mediated White Adipose Tissue Dysfunction and Impaired Insulin Signaling in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2022)

RF10 | PMON218 Direct Costs of Mental Health Disorders in PCOS: Systematic Review and Meta-Analysis
por: Bonner, Adam, et al.
Publicado: (2022)

THU636 Prevalence Of Metabolic Syndrome In A Sample Of Hispanic Patients With Polycystic Ovary Syndrome
por: Arroyo, Isabel C, et al.
Publicado: (2023)

THU635 Metabolic Characteristics Among Polycystic Ovary Syndrome-Phenotypes In A Sample Of Hispanic Patients
por: Gonzalez-Rodriguez, Loida Alejandra, et al.
Publicado: (2023)

The Relationship Between Hearing Thresholds and Hyperandrogenism in Polycystic Ovary Syndrome
por: Turan, Mahfuz, et al.
Publicado: (2016)

Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome
por: Donbaloğlu, Zeynep, et al.
Publicado: (2022)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

Ovarian Hyperthecosis: Hyperandrogenism in a Post-Menopausal Woman
por: Fayad, Christine, et al.
Publicado: (2021)

SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

OR35-03 Uncovering Causative Mutations in Polycystic Ovary Syndrome
por: Srivastava, Jaya, et al.
Publicado: (2023)

FRI409 Childbirth Experiences In Women With Polycystic Ovary Syndrome
por: Husby, Anne Engtrø, et al.
Publicado: (2023)

THU646 Postmenopausal Hyperandrogenism Secondary To Ovarian Leydig Cell Tumor
por: Batch, Jennifer Tania, et al.
Publicado: (2023)

SAT364 A Rare Cause of Hyperandrogenism in a Premenopausal Woman
por: Musa Penna, Laurianne El, et al.
Publicado: (2023)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Ovarian Aging-Like Phenotype in the Hyperandrogenism-Induced Murine Model of Polycystic Ovary
por: Rezvanfar, Mohammad Amin, et al.
Publicado: (2014)

Are Psychosocial Consequences of Obesity and Hyperandrogenism Present in Adolescent Girls with Polycystic Ovary Syndrome?
por: Zachurzok, Agnieszka, et al.
Publicado: (2018)

Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome
por: Velazquez, Mariela Edith, et al.
Publicado: (2021)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

RF34 | PMON202 The Human Metabolic Profile of Estetrol
por: Gérard, Céline, et al.
Publicado: (2022)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

SUN-018 No Difference in Breastfeeding Rates in Women with Polycystic Ovary Syndrome
por: Bui, Leeann, et al.
Publicado: (2020)

FRI457 Protein-coding Genetic Variation In Polycystic Ovary Syndrome
por: Parker, Chloe, et al.
Publicado: (2023)

OR35-06 Polycystic Ovary Syndrome Is Associated With an Increased Mortality Risk
por: Ollila, Meri-Maija, et al.
Publicado: (2023)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o0ddan4ed0a0vnt55ad0qgm9e0